The Sub-Committee on Biological Products ("CSM(B)") worked on its own. Linked evidence INQY1000211 - Transcript of Sir Michael David Rawlins - 07 Jun 2022 Chronology Information Date: 1 January 1976 Chapter/issue Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates